NextCure (NXTC) Other Accumulated Expenses (2019 - 2025)

NextCure's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $135000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 8.87% year-over-year to $135000.0; the TTM figure through Dec 2025 stood at $135000.0 (up 8.87% YoY), while the FY2025 annual figure was $135000.0, up 8.87% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $135000.0, up from $124000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $217000.0 in Q4 2021, with the low at $105000.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $124000.0 (2024), against an average of $138800.0.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses soared 1569.23% in 2021, then plunged 51.61% in 2022.
• NextCure's Other Accumulated Expenses stood at $217000.0 in 2021, then slumped by 51.61% to $105000.0 in 2022, then rose by 7.62% to $113000.0 in 2023, then climbed by 9.73% to $124000.0 in 2024, then advanced by 8.87% to $135000.0 in 2025.
• Business Quant data shows NXTC's Other Accumulated Expenses at $135000.0 in Q4 2025, $124000.0 in Q4 2024, and $113000.0 in Q4 2023.